导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 1.48% | 524/1050 |
| 近一周 | -0.74% | 408/1104 |
| 近一月 | -6.28% | 885/1103 |
| 近一季 | -12.09% | 788/1092 |
| 近半年 | -3.49% | 575/1070 |
| 近一年 | -6.40% | 682/1018 |
| 近两年 | 54.89% | 481/926 |
| 近三年 | 14.82% | 558/834 |
| 成立以来 | 45.68% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-2.51% 686/1070 |
27.74% 324/1101 |
- - |
- - |
| 2025 | 19.65% 676/1065 |
10.83% 131/1014 |
-0.11% 697/1038 |
21.72% 549/1050 |
-11.21% 922/1065 |
| 2024 | -1.45% 623/1011 |
-8.92% 736/960 |
-5.73% 674/983 |
10.94% 555/991 |
3.46% 180/1011 |
| 2023 | -12.50% 416/952 |
0.89% 583/880 |
-5.33% 548/895 |
-5.24% 330/915 |
-3.32% 358/952 |
| 2022 | -23.01% 437/867 |
-21.93% 634/773 |
10.82% 235/806 |
-12.12% 398/845 |
1.26% 368/867 |
| 2021 | 12.04% 218/740 |
-4.07% 306/580 |
10.46% 344/659 |
-3.70% 306/704 |
9.79% 90/740 |
| 2020 | - - |
- - |
- - |
18.42% 72/517 |
24.16% 79/554 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 朱雀企业优胜C VS. 东吴新产业精选股票A(580008) |